Elicio Therapeutics, Inc. - 8-K Filing

Elicio Therapeutics sets November 12, 2026 as the date for its 2026 annual meeting of stockholders. (Items: 5.08 Shareholder Director Nominations, 8.01 of this Current Report on Form 8-K “Notice of Annual Meeting” is incorporated by reference into this Item 5)

SEC EDGAR ·

Tickers: $ELTX

Read the full article at SEC EDGAR

More Regulatory news